Microfluidizer Á¾ÇÕÄ«´Ù·Î±×


Phone
  ´ëÇ¥ÀüÈ­ 1577-7956  
  º»     »ç 031-457-9187  
  ´ë     Àü 042-932-1265

Web Site Visitors
  Today 797    
  Yesterday 726    
  Since 2006 1,743,462    




Superior Nanoemulsion Production

Microfluidizer¢ç processors ´Â Ãʹ̼¼ droplet ÀÎ nano-emulsion Á¦Á¶¸¦ ¸Å¿ì È¿À²ÀûÀ¸·Î ÇÒ ¼ö ÀÖ´Ù. product ÀÇ formulation ÀÌ ÁÁÀ¸¸é Microfluidizer¢ç processors °¡ »ý»êÇÏ´Â nano-emulsion Àº Ãʹ̼¼ Å©±âÀÇ droplet ÀÌ°í droplet ÀÇ size ºÐÆ÷°¡ ¸Å¿ì ±ÕÀÏÇÏ¿© product ÀÇ ¾ÈÁ¤¼ºÀÌ ¸Å¿ì ¶Ù¾î³ª°Ô µÇ°í ¶ÇÇÑ ±× ´ÙÀ½ °øÁ¤¿¡¼­ filtration À» ÇÏ¿©µµ product ÀÇ loss °¡ ±ØÈ÷ Àû´Ù.

Microfluidizer¢ç processors Àåºñ¿¡¼­ product ¸¦ ºÐ»ê½ÃÅ°´Â ÀåÄ¡ÀÎ Interaction Chamber ´Â ³»ºÎ ±¸Á¶°¡ °íÁ¤µÇ¾î ÀÖ´Â fixed geometry ÇüÅ·ΠµÇ¾îÀÖ¾î 󸮿뷮ÀÌ 2ml ÀÎ ½ÇÇè¿ëÀåºñ¿¡¼­ ½ÇÇàÇÑ process ¸¦ ½Ã°£´ç ¼ö¹é¸®ÅÍ Ã³¸®ÇÏ´Â ´ëÇüÀåºñ¿¡¼­ ±×´ë·Î »ç¿ëÇÏ¿©µµ µ¿ÀÏÇÑ °á°ú¸¦ ±¸ÇÒ ¼ö ÀÖ´Ù´Â Å« Ư¡ÀÌ ÀÖ´Ù.

Microfluidizer¢ç processors ´Â »ç¿ëÇϱ⿡ ¸Å¿ì Æí¸®ÇÏ°í cGMP ±ÔÁ¤¿¡ ¿Ïº®È÷ ºÎÇÕµÇ°Ô ¼³°èµÇ¾î ÀÖ´Ù. Microfluidics ´Â ¼ö½Ê³â°£ ÃàÀûµÈ application °³¹ß ´É·Â°ú Àåºñ °³¹ß ´É·ÂÀ» ¹ÙÅÁÀ¸·Î °í°´¿©·¯ºÐÀÇ Á¦Ç° Ç°ÁúÀ» Çâ»ó½ÃÅ°°í È¿À²ÀûÀÎ »ý»ê °øÁ¤ °³¹ß¿¡ ÃÖ¼±À» ´ÙÇÏ°í ÀÖ´Ù.


Why do businesses choose Microfluidics for their nanoemulsion needs?


Proven Processing Solutions

Vaccine Adjuvant Nanoemulsion Collaboration with the Infectious Disease Research Institute (IDRI)



ÀڷẸ±â : Webinar recording with Dr. Chris Fox, Director of Formulations at IDRI


Unrivaled Uniform Particle Size Reduction

Ãʹ̼¼Å©±âÀÇ nano-emulsion Àº bioavailability ¸¦ Áõ°¡½ÃÅ°°í targeting ´É·ÂÀ» Çâ»ó½ÃŲ´Ù. ¿¹¸¦µé¾î ¾ÏÄ¡·áÁ¦·Î »ç¿ëµÇ´Â nano-emulsion ÀÇ °æ¿ì blood ¿Í brain barrier ¸¦ Åë°úÇÏ¿© ¼¼Æ÷ ³»ºÎ·Î µé¾î°¡´Â ´É·ÂÀÌ ¸Å¿ì Çâ»óµÈ´Ù.

nano-emulsion vaccine adjuvant ÀÇ Á¦Á¶¿¡¼­ Microfluidizer¢ç processors ¸¦ ÀÌ¿ëÇÏ¿© ±¸ÇÑ emulsion Àº °°Àº ¿¡³ÊÁö¸¦ »ç¿ëÇÏ´Â Á¶°Ç¿¡¼­ ´Ù¸¥ ÀÏ¹Ý °í¾ÐºÐ»êÀåºñ¸¦ »ç¿ëÇÏ¿´À» ¶§ º¸´Ù emulsion ÀÇ Å©±â°¡ 18 ~ 55% ´õ ÀÛ¾Ò´Ù. ±×¸®°í ÀÔÀÚ Å©±âÀÇ Ç¥ÁØÆíÂ÷ (standard deviation) ´Â 0.1 ~ 2.6 À¸·Î¼­ ´Ù¸¥ ÀÏ¹Ý °í¾ÐºÐ»êÀåºñ¿¡ ÀÇÇÑ emulsion Å©±âÀÇ Ç¥ÁØÆíÂ÷ (3.8 ~ 14.8) º¸´Ù ÈξÀ ÀÛ¾Ò´Ù. ÀÌ´Â Microfluidizer¢ç processors ¿¡ ÀÇÇØ Á¦Á¶µÈ nano-emulsion vaccine adjuvant ÀÇ nano-emulsion ÀÇ Å©±â°¡ ¸Å¿ì ±ÕÀÏÇÏ´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù.

ÀڷẸ±â : Webinar recording with Dr. Yang Su, New Technology Manager at Microfluidics titled Creating Nanoparticles with Microfluidizer High Shear Technology
See a poster comparing the Microfluidizer to a High Pressure Homogenizer for the professing of a vaccine adjuvant
Corixa Study Shows Microfluidizer¢ç Processor Results Superior to those of Leading Homogenizer (±¹¹®)


Improved Stability

¹°ÁúÀÇ Å©±â¸¦ ¹Ì¼¼ÇÏ°Ô Ã³¸®ÇÑ emulsion °ú suspension Á¦Ç°µéÀº ÃþºÐ¸®°¡ ÀϾ°Å³ª ħ°­ µî°ú °°Àº Çö»óÀÌ ÀϾ´Âµ¥ ÀÌ´Â ¸¹Àº ¿¬±¸ÀÚµé°ú »ý»ê´ã´çÀÚµéÀÌ Á÷¸éÇÏ´Â ¸Å¿ì Áß¿äÇÑ ¹®Á¦µéÀÌ´Ù. ÀÌ·¯ÇÑ ¹®Á¦µéÀÇ ÇØ°áÀº ºÐ»ê.À¯È­ ÀåºñµéÀÌ ¹°ÁúÀ» ¾î´ÀÁ¤µµ Ãʹ̼¼ÇÏ°Ô ±×¸®°í ¾î´ÀÁ¤µµ ±ÕÀÏÇÏ°Ô ºÐ»ê, À¯È­½ÃÅ°´À³Ä¿¡ ´Þ·ÁÀÖ´Ù. fixed-geometry ¹æ½ÄÀÇ interaction chamber ¸¦ »ç¿ëÇÏ´Â Microfluidizer¢ç processors ´Â ¾î´À Ÿ»ç Àåºñ¿¡ ºñÇØ °¡Àå ¹Ì¼¼ÇÏ°í ¶Ç °¡Àå ±ÕÀÏÇÑ nano-emulsion À» Á¦Á¶ÇÒ ¼ö ÀÖ´Ù. ±× °á°ú »ý»êµÈ Á¦Ç°ÀÇ ¾ÈÁ¤¼ºÀÌ ¶Ù¾î³ª°í À¯È¿±â°£µµ ÈξÀ ±æ°ÔµÈ´Ù.


Sterile Filtration

Microfluidizer¢ç processors ´Â ´Ù¸¥ ÀÏ¹Ý °í¾ÐºÐ»êÀåºñ º¸´Ù ó¸® pass ¼ö¸¦ Àû°Ô ÇÏ¿©µµ ¿øÇÏ´Â ÀÔÀÚÅ©±â¸¦ ¸¸µé¼ö ÀÖ¾î ¸Å¿ì È¿À²ÀûÀÌ´Ù. vaccine adjuvant Á¦Á¶¿Í °°Àº application Àº particle size reduction °øÁ¤ ´ÙÀ½¿¡ sterile filtration À» ÇØ¾ß ÇÏ´Â °æ¿ì°¡ Àִµ¥ ÀÌ °æ¿ì Microfluidizer processor ¸¦ ÀÌ¿ëÇÏ¸é ´ëºÎºÐÀÇ ÀÔÀÚÅ©±â°¡ 200nm ÀÌÇÏÀ̹ǷΠ¾ÆÁÖ ÀûÀº ¸éÀûÀÇ filter ¸¦ ÀÌ¿ëÇÏ¿© È¿À²ÀûÀ¸·Î sterile filtration À» ÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡ÀÌ ÀÖ´Ù.

ÀڷẸ±â : Webinar recording describing a collaboration with Pall titled Production & Sterilization of a Pharmaceutical Nanoemulsion Using Filtration
Poster detailing the Pall sterile filtration collaboration and results


Scalability

Microfluidics »ç´Â Microfluidizer processor ¸¦ ÀÌ¿ëÇÑ Scaleup ¿¡ ´ëÇÑ °á°ú¸¦ º¸ÀåÇÑ´Ù.




Quality Improvements

½ÄÇ° È­ÀåÇ° Á¦Ç°¿¡¼­ Åõ¸íÇÑ ¸ð¾ç°ú °°Àº Ư¡µéÀº Microfluidizer¢ç processors ¸¦ ÀÌ¿ëÇÏ¸é ´õ È¿À²ÀûÀ¸·Î ±¸ÇöÀÌ °¡´ÉÇÏ´Ù.




Nanotechnology in Pharmaceutical Applications

nano-emulsion Àº drug delivery mechanism ¿¡¼­ Á¡Á¡ ´õ Áß¿äÇÑ À§Ä¡¸¦ Â÷ÁöÇÏ°í ÀÖÀ¸¸ç Microfluidizer¢ç technology ´Â ÁÖ»çÁ¦·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ºÒ¿ëÇؼº ÀǾàÇ° °³¹ß¿¡ ¸Å¿ì
ÀÌ»óÀûÀÎ ±â¼úÀÌ´Ù.

Microfluidizer¢ç Àåºñ´Â ÀüÅëÀûÀÎ emulsion ±â¹ýÀÌ º»ÁúÀûÀ¸·Î °¡Áö°í ÀÖ´Â solubility, stability
±×¸®°í sterilization °ú °°Àº ÇÑ°èµéÀ» ¶Ù¾î ³ÑÀ» ¼ö ÀÖ´Â Àåºñ¶ó ÇÒ ¼ö ÀÖ´Ù.
¾Æ·¡ ³»¿ëµéÀº Á¦¾à ºÐ¾ß¿¡¼­ »ç¿ëµÉ ¼ö ÀÖ´Â nano-technology ¿¡ °üÇØ ¼³¸íÇÏ´Â webinar µéÀÌ´Ù.

ÀڷẸ±â : Theranostic Nanoemuslions for Inflammatory Diseases From Design to Scale Up & Beyond
Nanoemulsions for CNS Delivery of Biological Therapeutics


Additional References

Nano-Scale Double Emulsions Stabilized By Single-Component Block Copolypeptides (paper)
Effects of Homogenization Models and Emulsifiers On The Physicochemical Properties of ©¬ - Carotene Nano-Emulsions (paper)
Thermodynamic Signature of Secondary Nano-Emulsion Formation By Isothermal Titration Calorimetry (paper)
Cyclooxgenase - 2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nano-Emulsions - In-Vitro Study (paper)
An Alternative Renewable Source of Squalene For Use In Emulsion Adjuvants (paper)
Optimizing Manufacturing and Composition of A TLR4 Nano-Suspension - Physicochemical Stability and Vaccine Adjuvant Activity (paper)
Technology Transfer of Oil-In-Water Emulsion Adjuvant Manufacturing For Pandemic Influenza Vaccine Production In Romania (paper)
Effects On Immunogenicity By Formulations of Emulsion-Based Adjuvants For Malaria Vaccines (paper)
Squalane Nanoemulsion Processed with Microfluidizer M-110P (webinar)











 
(ÁÖ)¿µÁøÄÚÆÛ·¹ÀÌ¼Ç   |   ´ëÇ¥ : ÀÌÇü¿­   |   »ç¾÷ÀÚµî·Ï¹øÈ£ : 138-81-34745
±º Æ÷ º» »ç   |   (15853) °æ±âµµ ±ºÆ÷½Ã ÇѼ¼·Î 48 ³²¿øºôµù 2Ãþ   |   ÀüÈ­ : 1577-7956 (1)   |   Æѽº : 031-457-9188   |   À̸ÞÀÏ : info@yjcorp.co.kr
´ë Àü Áö »ç   |   (34036) ´ëÀü½Ã À¯¼º±¸ Å×Å©³ë10·Î 29 ÆÄÅ©ÆÓ¸®½º 2Ãþ   |   ÀüÈ­ : 1577-7956 (2)   |   Æѽº : 042-932-1266   |   À̸ÞÀÏ : info@yjcorp.co.kr